Mindfulness-Based Stress Reduction to Improve Well-being in Black Adult Cancer Survivors, Community Faith-based Mindfulness Ministry

NCT ID: NCT06767475

Last Updated: 2025-05-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

115 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-31

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical trial evaluates the impact of a Mindfulness-Based Stress Reduction (MBSR) program adjusted to include Christian principles on well-being in Black adult cancer survivors. Cancer survivors face a unique set of challenges that includes not only physical but also mental and spiritual well-being. Concerns related to both diagnosis and treatment profoundly impact the quality of life of Black cancer survivors. Mindfulness-based interventions (MBIs) have been shown to be effective in improving psychological resilience, reducing anxiety, and enhancing the quality of life among cancer survivors. However, there is little research focusing on these interventions among Black adult cancer survivors. Research has shown that interventions that include cultural experiences, such as the role of religion, spirituality and faith, are more effective in maintaining psychological well-being in Black men. A MBSR program adjusted to include Christian principles may improve the well-being in Black adult cancer survivors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. Develop a culturally adapted Mindfulness-Based Stress Reduction (MBSR) intervention. (Phase 0) II. Pilot test the MBSR intervention to assess its feasibility, acceptability, and preliminary efficacy among a small group of participants. (Phase 0)

OUTLINE:

PHASE 0:

INTERVENTION DEVELOPMENT: Participants attend a focus group or a one-on-one interview over up to 60 minutes to gather insights of the cultural needs of Black adult cancer survivors.

PILOT TESTING: Patients participate in a group discussion with exercises and activities on study.

After completion of study intervention, patients are followed up at 3 months.

PHASE 1: Patients participate in group discussions, exercises, and activities over no more than 8 hours for up to 3 sessions (up to 16 hours total) within 8 weeks.

PHASE 2: Patients are randomized to 1 of 2 groups.

GROUP I (INTERVENTION): Patients participate in group discussions, exercises, and activities over no more than 8 hours for up to 3 sessions (up to 16 hours total).

GROUP II (CONTROL): Patients receive usual care on study.

After completion of study intervention, patients are followed up at 3 and 6 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I (MBSR)

Patients participate in group discussions, exercises, and activities over no more than 8 hours for up to 3 sessions (up to 16 hours total).

Group Type EXPERIMENTAL

Health Promotion

Intervention Type OTHER

Participate in group discussion with exercises and activities

Questionnaire Administration

Intervention Type OTHER

Ancillary studies

Group II (control)

Patients receive usual care on study.

Group Type ACTIVE_COMPARATOR

Best Practice

Intervention Type OTHER

Receive usual care

Questionnaire Administration

Intervention Type OTHER

Ancillary studies

Phase 0 (intervention development, pilot testing)

INTERVENTION DEVELOPMENT: Participants may attend a focus group or a one-on-one interview over up to 60 minutes to gather insights of the cultural needs of Black adult cancer survivors.

PILOT TESTING: Patients participate in a group discussion with exercises and activities on study.

Group Type EXPERIMENTAL

Discussion

Intervention Type OTHER

Attend a focus group

Health Promotion

Intervention Type OTHER

Participate in group discussion with exercises and activities

Interview

Intervention Type OTHER

Attend a one-on-one interview

Questionnaire Administration

Intervention Type OTHER

Ancillary studies

Phase 1 (MBSR)

Patients participate in group discussions, exercises, and activities over no more than 8 hours for up to 3 sessions (up to 16 hours total) within 8 weeks.

Group Type EXPERIMENTAL

Health Promotion

Intervention Type OTHER

Participate in group discussion with exercises and activities

Questionnaire Administration

Intervention Type OTHER

Ancillary studies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Best Practice

Receive usual care

Intervention Type OTHER

Discussion

Attend a focus group

Intervention Type OTHER

Health Promotion

Participate in group discussion with exercises and activities

Intervention Type OTHER

Interview

Attend a one-on-one interview

Intervention Type OTHER

Questionnaire Administration

Ancillary studies

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

standard of care standard therapy Discuss Health Promotion (Salutogenesis) Health Promotion and Wellness Mindfulness Health Promotion Salutogenesis

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* PHASE 0 DEVELOPMENT: Adults aged 18 or older
* PHASE 0 DEVELOPMENT: Ability to speak, read and understand English
* PHASE 0 DEVELOPMENT: Individuals personally affected by cancer, either through their own diagnosis or that of a loved one
* PHASE 0 DEVELOPMENT: Self-identifies as Black or African American
* PHASE 0 DEVELOPMENT: Membership or affiliation with a faith-based organization
* PHASE 0 PILOT TESTING: Adults aged 18 or older
* PHASE 0 PILOT TESTING: History of a cancer diagnosis
* PHASE 0 PILOT TESTING: Meets National Cancer Institute (NCI) cancer survivor definition (a person is a survivor from the time of diagnosis until the end of life)
* PHASE 0 PILOT TESTING: Ability to physically attend live MBI and complete web-based surveys and assessments
* PHASE 0 PILOT TESTING: Ability to speak, read and understand English
* PHASE 1: Adults aged 18 or older
* PHASE 1: History of a cancer diagnosis
* PHASE 1: Meets NCI cancer survivor definition (a person is a survivor from the time of diagnosis until the end of life)
* PHASE 1: Ability to physically attend live MBI and complete web-based surveys and assessments
* PHASE 1: Ability to speak, read and understand English
* PHASE 2: Adults aged 18 or older
* PHASE 2: History of a cancer diagnosis
* PHASE 2: Meets NCI Cancer Survivor definition (a person is a survivor from the time of diagnosis until the end of life)
* PHASE 2: Ability to physically attend live MBI and complete web-based surveys and assessments
* PHASE 2: Ability to speak, read and understand English

* PHASE 0 DEVELOPMENT: Unable or unwilling to participate in the recorded sessions
* PHASE 0 PILOT TESTING: Inability to attend and participate in MBI due to medical or psychological hardship
* PHASE 0 PILOT TESTING: Inability to speak, read and understand English
* PHASE 1: Inability to attend and participate in MBI due to medical or psychological hardship
* PHASE 1: Inability to speak, read and understand English
* PHASE 1: Participated in phase 0 of the study
* PHASE 2: Inability to attend and participate in MBI due to medical or psychological hardship
* PHASE 2: Inability to speak, read and understand English
* PHASE 2: Participated in phase 0 or phase 1 of the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mayo Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Floyd B. Willis, MD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Floyd B. Willis, MD

Role: PRINCIPAL_INVESTIGATOR

Mayo Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Clinic in Florida

Jacksonville, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2024-10490

Identifier Type: REGISTRY

Identifier Source: secondary_id

MC240901

Identifier Type: OTHER

Identifier Source: secondary_id

24-006322

Identifier Type: OTHER

Identifier Source: secondary_id

MC240901

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.